Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cells efficiently induce protective antiviral immunity

B Ludewig1, S Ehl, U Karrer

  • 1Institute of Experimental Immunology, Zürich, Switzerland. LudewigB@pathol.unizh.ch

Journal of Virology
|April 29, 1998
PubMed
Summary

Dendritic cells (DC) efficiently induce potent, long-lasting antiviral immunity by activating cytotoxic T lymphocytes (CTL). This DC-based immunization strategy offers rapid and durable protection against viral infections, making it promising for vaccine development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotype.

Blood cells, molecules & diseases·2017
Same author

Reactive oxygen species delay control of lymphocytic choriomeningitis virus.

Cell death and differentiation·2013
Same author

Simulation of the interferon-mediated protective field in lymphoid organs with their spatial and functional organization taken into consideration.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections·2011
Same author

Ablation of Cx47 in transgenic mice leads to the loss of MUPP1, ZONAB and multiple connexins at oligodendrocyte-astrocyte gap junctions.

The European journal of neuroscience·2008
Same author

[Uro-oncological research from the laboratory and clinical practice].

Der Urologe. Ausg. A·2008
Same author

Hepatocellular integrity in patients requiring parenteral nutrition: comparison of structured MCT/LCT vs. a standard MCT/LCT emulsion and a LCT emulsion.

European journal of anaesthesiology·2008

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Cytotoxic T lymphocytes (CTL) are crucial for controlling viral infections.
  • Effective CTL responses require rapid antigen presentation, which can be challenging due to high viral replication rates.
  • Dendritic cells (DC) are potent antigen-presenting cells capable of priming naive CTL.

Purpose of the Study:

  • To evaluate the efficacy of dendritic cells (DC) in inducing lymphocytic choriomeningitis virus (LCMV)-specific antiviral immunity in vivo.
  • To compare different routes of DC administration and assess the required number of DC for effective CTL activation.
  • To determine the speed, duration, and protective capacity of DC-induced immune responses against viral challenge.

Main Methods:

  • Mice were immunized intravenously with DC pulsed with LCMV-specific peptide GP33-41 or DC constitutively expressing the epitope.

Related Experiment Videos

  • The number of DC required to reach the spleen for protective CTL activation was determined.
  • Mice were challenged with LCMV or recombinant vaccinia virus-LCMV to assess protection and viral clearance.
  • Ex vivo cytotoxicity assays were performed to measure CTL activity.

    • Main Results:

    • A low number of DC (100-1,000) reaching the spleen induced protective CTL activation.
    • DC immunization resulted in rapid (detectable by day 4) and long-lasting (protected at day 60) antiviral immunity.
    • Mice immunized with DC were protected against lethal LCMV challenge and cleared viral infections from peripheral organs like the brain and ovaries.
    • In vivo CTL priming with peptide-loaded DC was not limited by peptide-MHC class I complex turnover.

    Conclusions:

    • Dendritic cell-based immunization is a highly efficient method for priming antiviral CTL responses.
    • DC-induced immunity is rapid, robust, and provides long-term protection against viral infections.
    • The use of DC represents a promising strategy for developing effective antiviral vaccines.